These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vaccinating adolescents and young women against cancer of the cervix. Hilgers RD; Wyatt SW J Ky Med Assoc; 2007 May; 105(5):215-6. PubMed ID: 17566465 [No Abstract] [Full Text] [Related]
5. Herd immunity. O'Connor K Aust Fam Physician; 2007 Sep; 36(9):677. PubMed ID: 17915372 [No Abstract] [Full Text] [Related]
6. One in four California adolescent girls have had human papillomavirus vaccination. Grant D; Kravitz-Wirtz N; Breen N; Tiro JA; Tsui J Policy Brief UCLA Cent Health Policy Res; 2009 Feb; (PB2009-3):1-6. PubMed ID: 19288623 [No Abstract] [Full Text] [Related]
7. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health. Harper DM Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance. Gold MS; McIntyre P Sex Health; 2010 Sep; 7(3):320-4. PubMed ID: 20719221 [TBL] [Abstract][Full Text] [Related]
9. [In defence of women against HPV-infection]. Blázovics A Orv Hetil; 2007 Apr; 148(17):813. PubMed ID: 17452313 [No Abstract] [Full Text] [Related]
10. Towards global prevention of human papillomavirus-induced cancer. Roden RB; Gravitt P; Wu TC Eur J Immunol; 2008 Feb; 38(2):323-6. PubMed ID: 18228245 [No Abstract] [Full Text] [Related]
12. [Safety of the bivalent human papillomavirus vaccine--results following administration of more than 192,000 doses]. van der Maas NA; Kemmeren JM; de Melker HE Ned Tijdschr Geneeskd; 2009; 153():A964. PubMed ID: 19930738 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccines: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs? Jacob M; Bradley J; Barone MA Sex Transm Dis; 2005 Oct; 32(10):635-40. PubMed ID: 16205306 [No Abstract] [Full Text] [Related]
14. Primary and secondary prevention of cervical cancer--opportunities and challenges. Markowitz LE; Unger ER; Saraiya M J Natl Cancer Inst; 2009 Apr; 101(7):439-40. PubMed ID: 19318638 [No Abstract] [Full Text] [Related]
16. Trends in Genital Warts in the Era of Human Papillomavirus Vaccination. Calo WA; Brewer NT Sex Transm Dis; 2015 Dec; 42(12):669-70. PubMed ID: 26560967 [No Abstract] [Full Text] [Related]
17. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types. Herrero R J Infect Dis; 2009 Apr; 199(7):919-22. PubMed ID: 19236278 [No Abstract] [Full Text] [Related]
19. HPV related surveillance activities in Australia. Brotherton J; Kaldor JM; McIntyre P Vaccine; 2010 Nov; 28(47):7453-4. PubMed ID: 20854898 [No Abstract] [Full Text] [Related]
20. Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available? Porta M; González B; Márquez S; Artazcoz L J Epidemiol Community Health; 2008 Aug; 62(8):667. PubMed ID: 18621949 [No Abstract] [Full Text] [Related] [Next] [New Search]